Mission of SiteRx
SiteRx is on a mission to bridge clinical trials with clinical practice, making access to appropriate clinical trials available to any patient that qualifies and wishes to participate. By accomplishing this, we give treating physicians an opportunity to provide additional care options for their patients while generating significant new income for their practices. We also improve things dramatically for sponsors and sites who consistently struggle to recruit the right patients, wasting precious time and money, and delaying the approval of potentially life-saving treatments.
Our CEO and Founder, Seth Goodman, grew up watching his father dedicate his life to Alzheimer’s disease patients and their families, devoting all of his time to care and research. Seth founded SiteRx to make his father’s life easier and to empower patients to take control of research opportunities for their medical conditions.
SiteRx’s long-term mission is to revolutionize the way healthcare opportunities are delivered to patients. We strive to promote diversity and inclusion in clinical research. By bringing ground-breaking treatments to the market more efficiently, we hope to deliver the first cure for Alzheimer’s disease for the benefit of every patient.
Founder and CEO
Seth grew up in a family of doctors. After observing his father dedicate his life to find a cure for Alzheimer’s Disease, Seth decided to work on healthcare-focused technology at Columbia Business School to help propel that mission forward. Previously, Seth worked in technology and investing.
Co-Founder and CTO
Manoj is a seasoned IT executive and Entrepreneur with 20 years of experience in Enterprise Architecture, Software development, Project and Program Management, teaching and mentoring. He focuses on Natural Language Processing, Machine Learning, Predictive Analytics, Cloud Computing and Big Data.
Scientific Advisory Board
Rudy Tanzi, Ph.D. serves as the Vice Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital. He is also the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University. Tanzi has played a pivotal role in helping to identify genotypes predictive of the expression and relative risk of developing Alzheimer's and Wilson's disease.
Chief Operating Officer
Michael is the head of operations for SiteRx, focusing on growing and activating our physician network nationwide. Prior to SiteRx, Michael worked in technology advisory at Evercore, and supported early stage startups as an associate for a healthcare-focused incubator.